Clinical Trials in Chronic Lymphocytic Leukaemia (CLL)

 

Trial Name

 

Trial Summary

 

Hyperlink

 

FLAIR

 

This trial is comparing ibrutinib alongside rituximab with fludarabine, cyclophosphamide, rituximab and venetoclax for chronic lymphocytic leukaemia. This trial is for people who haven’t yet had treatment for their chronic lymphocytic leukaemia (CLL)

 

More details

BGB-3111-305

Zanubrutinib for patients with relapsed or refractory CLL

More details